https://channeldrive.in
Accenture has invested, through Accenture Ventures, in 1910 Genetics (or “1910”), a biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. As part of this investment, Accenture and 1910 will collaborate to combine tailored solutions and scalable infrastructure to help clients in the biopharma industry accelerate […]
The post Accenture Invests in 1910 Genetics to Transform Drug Discovery appeared first on Channel Drive.